ArticleThe Journal of urology2020

Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.

Guru Sonpavde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.